January Newsletter
It has been a month into 2025, and the pharma industry is buzzing with news and emerging trends. Now is also a good time to look back at last year and recognize accomplishments that are shaping the future.??
Here’s what’s making headlines:?
Why Are Pharma Giants Only Now Investing Billions in Radiopharmaceuticals??
Radiopharmaceuticals have been around for nearly a century, but only recently have they attracted significant investment. Why? This has much to do with the tech advancements that allow for precise tumor targeting with minimal side effects. Besides, manufacturing costs have dropped, and new methods have emerged to deliver these short-shelf-life treatments to patients.?
Read on to explore Novartis’ success in this field and discover what lies ahead for the industry.?
?
2025 Seems Promising for Pharma?
Pharma has faced plenty of curveballs over the past couple of years, from tight research and development budgets to patent cliffs. But this year holds the promise of change, and there are good reasons to believe it.??
Click here to catch the latest 2025 trends!?
The EU Action Plan Sets to Strengthen Cybersecurity??
The EU’s new action plan aims to improve cybersecurity throughout European healthcare facilities. This comes amidst a surge in cyber threats, including vulnerabilities in both software and hardware, the ever-present danger of ransomware, and the disruptive impact of DDoS attacks.??
领英推荐
While this 23-page document might sound like a bold mission for many, it offers a holistic approach to the security problem. Hospitals will use it to better identify cyber threats, enhance their preparedness, and elaborate their responses.??
Learn more by following the link below:?
UK Phase I Advanced Therapy Trials Surge in 2024?
Cell and gene therapy clinical trials grew by 7% in the UK last year, with an impressive 70% rise in Phase I trials. What does this mean for the UK? This boost in early-stage research builds critical skills and expertise across the country. It also means patients gain quicker access to life-saving new treatments.?
Check out the full post:?
OpenAI Partners with Retro Biosciences to Create a New AI Model?
This partnership has a clear goal: to develop GPT-4b, a machine learning model for bioengineering. Simply put, this model will accurately predict how proteins interact. This, in turn, will help discover treatments for a range of life-altering conditions like diabetes and blindness.?
Read this brief article here:?
Trump Is Withdrawing the US from the World Health Organization (WHO)?
From day one of his presidency, Trump began the process of withdrawing the United States from the WHO, marking the end of 76 years of cooperation.??
The implications are palpable. With the U.S. contributing 22% of the WHO’s funding, some global health missions and international response efforts can be in question.?
Discover Trump’s reasoning behind this decision and the potential challenges it poses to global health:?
?